Favorable outcome of COVID-19 in a young woman with severe Crohn’s disease on regular use of adalimumab and prednisone: a case report

Vechi, Hareton TeixeiraMaia, Lucas RodriguesAlves, Manoela do MonteRodrigues-Neto, João Firmino2022-02-182022-02-182020VECHI, Hareton Teixeira et al. Favorable outcome of COVID-19 in a young woman with severe Crohn’s disease on regular use of adalimumab and prednisone: a case report. Revista do Instituto de Medicina Tropical de São Paulo, [s. l.], v. 62, p. 1-6, 2020. Disponível em: https://www.scielo.br/j/rimtsp/a/G39mZmZfxz3Xnqkn3ff8fby/?lang=en. Acesso em: 16 fev. 2022. http://dx.doi.org/10.1590/s1678-99462020621021678-9946 (online)0036-4665 (print)https://repositorio.ufrn.br/handle/123456789/46067Attribution-NonCommercial 3.0 Brazilhttp://creativecommons.org/licenses/by-nc/3.0/br/COVID-19Crohn’s diseaseTNF inhibitorSARS-CoV-2Favorable outcome of COVID-19 in a young woman with severe Crohn’s disease on regular use of adalimumab and prednisone: a case reportarticle10.1590/s1678-9946202062102